Kindred Biosciences, Inc. (KIN): Price and Financial Metrics


Kindred Biosciences, Inc. (KIN): $9.25

0.01 (+0.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add KIN to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

KIN Stock Price Chart Interactive Chart >

Price chart for KIN

KIN Price/Volume Stats

Current price $9.25 52-week high $9.28
Prev. close $9.24 52-week low $3.46
Day low $9.24 Volume 178,400
Day high $9.26 Avg. volume 840,890
50-day MA $9.19 Dividend yield N/A
200-day MA $5.89 Market Cap 420.52M

Kindred Biosciences, Inc. (KIN) Company Bio


Kindred Biosciences, Inc., a development stage biopharmaceutical company, focuses on the development of therapies for pets. The company’s product pipeline consists of small molecules and biologics for a range of indications in dogs, cats, and horses. The company was founded in 2012 and is based in Burlingame, California.


KIN Latest News Stream


Event/Time News Detail
Loading, please wait...

KIN Latest Social Stream


Loading social stream, please wait...

View Full KIN Social Stream

Latest KIN News From Around the Web

Below are the latest news stories about Kindred Biosciences Inc that investors may wish to consider to help them evaluate KIN as an investment opportunity.

INVESTIGATION: Halper Sadeh LLP Investigates SYKE, MCF, ONEM, KIN; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / August 17, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:Sykes Enterprises, Incorporated (NASDAQ:SYKE)concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Sitel Group for $54. If you are a Sykes shareholder, click here to learn more about your rights and options.

Yahoo | August 18, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds KIN, SYKE, MNR, and QTS Shareholders About Its Ongoing Investigations

If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

Yahoo | August 17, 2021

SHAREHOLDER ALERT: Monteverde & Associates PC Continues to Investigate the Following Merger

NEW YORK, NY / ACCESSWIRE / August 16, 2021 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating: * Kindred Biosciences, Inc. (NASDAQ:KIN) relating to its proposed acquisition by Elanco Animal Health, Inc.

Yahoo | August 16, 2021

INVESTIGATION: Halper Sadeh LLP Investigates BRBS, KIN, MNR, IKNX; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / August 11, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:Blue Ridge Bankshares, Inc. (NYSE American:BRBS)concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with FVCBankcorp, Inc.

Yahoo | August 11, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds SQ, TBIO, KIN, and MNR Shareholders About Its Ongoing Investigations

If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

Yahoo | August 10, 2021

Read More 'KIN' Stories Here

KIN Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 1.31%
3-year 10.65%
5-year 8.82%
YTD N/A
2021 0.00%
2020 -49.17%
2019 -22.56%
2018 15.87%
2017 122.35%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5082 seconds.